Clinical Trial Update: Treatment of Keratoconus Using Collagen Cross-Linking [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating collagen cross-linking with riboflavin for keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Riboflavin (riboflavin)

Snippet

Sponsor: University at Buffalo | Conditions: Keratoconus | Phase 2, Phase 3 | Status: UNKNOWN